Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial

Edmund K Bartlett1, Christopher A Barker2

  • 1Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bartlete@mskcc.org.

Abstract

No abstract available in PubMed .